Physiological Biomarker-Based Neural Dosing Study: A prospective, multicenter, single-arm study evaluating the clinical utility of biomarker-based neural dosing using evoked compound action potential (ECAP)-controlled closed-loop spinal cord stimulation (SCS).

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Registry
Year 2026
This article has no abstract
Epistemonikos ID: ab6668ef5b7c42acdcd85a4a3af78608d4553b2a
First added on: Sep 12, 2026